Medicare Will Cover Avastin Despite FDA Ruling
The Centers for Medicare and Medicaid Services said Thursday that Roche Holding Ltd.'s drug Avastin will continue to be covered by Medicare for breast cancer treatment, despite a negative recommendation by...To view the full article, register now.
Already a subscriber? Click here to view full article